InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by WOODHOUSE DAVID J, Chairman & CEO. Insider active across 1 company, notably NGM Biopharmaceuticals INC. In total, 4 filings have been published. Activity tracked since 18 November 2021. The latest transaction was filed on 29 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
12,987 shares@ US$7.7046.9% of flowCommon StockSEC:0001209191-21-071613
12,987 shares@ US$7.7023.5% of flowCommon StockSEC:0001209191-21-071613:0
15,000 shares@ US$7.5426.5% of flowCommon StockSEC:0001209191-21-065973:0
15,000 shares@ US$7.5453.1% of flowCommon StockSEC:0001209191-21-065973
4 of 4 declarations
About WOODHOUSE DAVID J
David J. Woodhouse is the CEO of NGM Biopharmaceuticals Inc. He leads the company with a vision focused on innovation in the biopharmaceutical sector. His experience is essential for strategic development.
